Spain Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Spain Pharmaceuticals and Healthcare Report Q3 2013 Jul 10th 2013, 00:00, by rnrmahesh BMI View: The deterioration of the Spanish economy and the government’s implementation of increasingly aggressive fiscal austerity policies that focus on cost containment in the healthcare sector will lead to yearly declines in pharmaceutical spending, at least until 2017. Our view is supported by the success of previous government measures, including the steep decline in state spending on medicines and the drop in average expenditure per prescription following the implementation of Royal Decree Laws 4 and 8/2010, Royal Decree Law 9/2011 and Royal Decree Law 16/2012. Headline Expenditure Projections ? Pharmaceuticals: EUR18.34bn (US$23.30bn) in 2012 to EUR16.44bn (US$21.86bn) in 2013; … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=106034. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/spain-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions